Marcus J Schultz Selected Research

Shock

4/2022	Myocardial Function during Ventilation with Lower versus Higher Positive End-Expiratory Pressure in Patients without ARDS.
12/2020	Pragmatic Recommendations for the Management of COVID-19 Patients with Shock in Low- and Middle-Income Countries.
8/2017	Balanced versus isotonic saline resuscitation-a systematic review and meta-analysis of randomized controlled trials in operation rooms and intensive care units.
1/2017	Clinical Characteristics and Outcomes of Patients With Cellulitis Requiring Intensive Care.
3/2016	Chronic antiplatelet therapy is not associated with alterations in the presentation, outcome, or host response biomarkers during sepsis: a propensity-matched analysis.
11/2015	Plasma fractalkine is a sustained marker of disease severity and outcome in sepsis patients.
1/2009	Mechanical ventilation using non-injurious ventilation settings causes lung injury in the absence of pre-existing lung injury in healthy mice.
5/2008	Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcus J Schultz Research Topics

Disease

115	Critical Illness (Critically Ill) 04/2024 - 01/2004
72	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2024 - 07/2004
69	Sepsis (Septicemia) 01/2024 - 05/2003
67	Lung Injury 04/2024 - 10/2006
65	Pneumonia (Pneumonitis) 04/2024 - 01/2002
63	Inflammation (Inflammations) 04/2024 - 04/2003
55	Infections 01/2023 - 04/2003
41	COVID-19 02/2024 - 01/2020
31	Acute Lung Injury 12/2023 - 05/2003
23	Ventilator-Induced Lung Injury 01/2021 - 07/2008
16	Acute Kidney Injury (Acute Renal Failure) 12/2021 - 10/2006
16	Hypoxia (Hypoxemia) 11/2021 - 03/2008
15	Ventilator-Associated Pneumonia 05/2024 - 01/2004
13	Pulmonary Atelectasis 01/2023 - 10/2012
12	Respiratory Insufficiency (Respiratory Failure) 07/2023 - 04/2008
12	Pulmonary Edema 01/2023 - 01/2009
11	Hypoglycemia (Reactive Hypoglycemia) 07/2017 - 01/2006
10	Body Weight (Weight, Body) 01/2021 - 01/2010
9	Hypothermia 01/2022 - 01/2009
9	Wounds and Injuries (Trauma) 01/2021 - 02/2008
8	Hyperoxia 01/2023 - 01/2014
8	Shock 04/2022 - 05/2008
8	Pneumococcal Pneumonia 11/2021 - 01/2008
7	Pneumothorax 05/2024 - 05/2015
7	Hemorrhage 01/2021 - 01/2007
7	Heart Arrest (Cardiac Arrest) 12/2020 - 01/2008
6	Endotoxemia 01/2023 - 04/2010
6	Burns 01/2021 - 01/2011
6	Transfusion-Related Acute Lung Injury 10/2012 - 02/2010
5	Septic Shock (Toxic Shock Syndrome) 01/2021 - 01/2008
4	Bacteremia 01/2022 - 10/2014
4	Human Influenza (Influenza) 01/2021 - 03/2010
4	Diabetes Mellitus 05/2020 - 01/2006
4	Peritonitis 01/2016 - 11/2006
4	Renal Insufficiency (Renal Failure) 08/2011 - 08/2005
3	Communicable Diseases (Infectious Diseases) 01/2023 - 01/2022
3	Necrosis 01/2023 - 03/2014
3	Thrombosis (Thrombus) 01/2022 - 01/2007
3	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2007

Drug/Important Bio-Agent (IBA)

65	Biomarkers (Surrogate Marker)IBA 02/2024 - 08/2006
28	Oxygen (Dioxygen)IBA 12/2023 - 11/2006
24	CytokinesIBA 01/2023 - 01/2002
22	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2003
19	LipopolysaccharidesIBA 06/2021 - 07/2010
19	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2006
18	AnticoagulantsIBA 01/2021 - 05/2003
16	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 01/2007
13	Protein CIBA 11/2017 - 09/2005
12	FibrinIBA 01/2022 - 04/2003
12	AntithrombinsIBA 11/2017 - 11/2006
10	Thrombin FDA Link 09/2015 - 05/2003
9	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 08/2009
9	Thromboplastin (Tissue Factor)IBA 11/2018 - 06/2006
8	Volatile Organic CompoundsIBA 03/2023 - 01/2014
8	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2010
8	Insulin (Novolin)FDA Link 07/2017 - 01/2006
7	ChemokinesIBA 01/2023 - 01/2002
7	CreatinineIBA 01/2023 - 11/2009
7	Receptor for Advanced Glycation End ProductsIBA 11/2020 - 02/2010
7	Blood Glucose (Blood Sugar)IBA 01/2017 - 07/2011
6	Complement System Proteins (Complement)IBA 12/2020 - 01/2016
6	danaparoid (Orgaran)FDA Link 11/2017 - 01/2007
6	Plasminogen Activators (Plasminogen Activator)IBA 10/2012 - 06/2006
5	Lactic Acid (Lactate)FDA LinkGeneric 03/2023 - 01/2006
5	MacrolidesIBA 01/2022 - 07/2004
5	lipoprotein-associated coagulation inhibitor (TFPI)IBA 11/2017 - 02/2007
4	LipidsIBA 01/2024 - 10/2007
4	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2023 - 02/2010
4	Triggering Receptor Expressed on Myeloid Cells-1IBA 01/2023 - 08/2006
4	EnzymesIBA 01/2023 - 12/2016
4	Neuromuscular Blocking AgentsIBA 01/2021 - 08/2005
4	Interleukin-8 (Interleukin 8)IBA 12/2020 - 11/2009
4	Acetylcysteine (Siran)FDA LinkGeneric 12/2020 - 01/2006
4	Hypnotics and Sedatives (Sedatives)IBA 10/2020 - 01/2007
4	Saline SolutionIBA 03/2020 - 01/2009
4	AntibodiesIBA 01/2018 - 10/2007
4	Fibrin Fibrinogen Degradation ProductsIBA 10/2011 - 01/2009
3	octaneIBA 09/2023 - 08/2021
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 12/2020
3	Messenger RNA (mRNA)IBA 01/2023 - 05/2017
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2022 - 06/2006
3	C-Reactive ProteinIBA 09/2021 - 12/2015

Therapy/Procedure

100	Artificial Respiration (Mechanical Ventilation) 05/2024 - 04/2005
52	Therapeutics 05/2024 - 05/2003
48	Mechanical Ventilators (Ventilator) 05/2024 - 11/2005
38	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 06/2023 - 10/2006
25	Critical Care (Surgical Intensive Care) 01/2023 - 09/2005
21	Length of Stay 05/2024 - 01/2006
12	Glycemic Control 01/2017 - 09/2005
9	Resuscitation 01/2021 - 01/2010
8	Tracheostomy 11/2022 - 01/2020
7	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2023 - 01/2007
7	Induced Hypothermia 01/2020 - 01/2008
5	Extracorporeal Membrane Oxygenation 03/2024 - 11/2016
5	General Anesthesia 12/2023 - 01/2014
5	Continuous Renal Replacement Therapy 05/2008 - 01/2006
4	Noninvasive Ventilation 01/2021 - 04/2012
3	Immunomodulation 01/2022 - 07/2004
3	Aftercare (After-Treatment) 01/2021 - 08/2012
3	Central Venous Catheters 01/2021 - 11/2011